Otolaryngologist, head and neck surgeon Francis T. Hall discusses the evaluation of thyroid nodules, which primarily aims to determine the likelihood of malignancy. He then reviews the treatment of thyroid nodules and thyroid cancer, including recent advances in management
Decision to fund bedaquiline and linezolid for multi-drug resistant tuberculosis
+Undoctored
Decision to fund bedaquiline and linezolid for multi-drug resistant tuberculosis
Tuesday 13 June 2023, 01:29 PM

Pharmac will fund bedaquiline and linezolid for multi-drug resistant tuberculosis (MDR-TB) from 1 July 2023
We're pleased to announce that from 1 July 2023 bedaquiline and linezolid will be funded for multi-drug resistant tuberculosis (MDR-TB) for both community and hospital use. This change will enable people with MDR-TB to be treated in the community where appropriate.